Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease
Authors
Keywords
-
Journal
MOVEMENT DISORDERS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-09-04
DOI
10.1002/mds.28779
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study
- (2020) Frank de Wolf et al. BRAIN
- CSF NFL in a Longitudinally Assessed PD Cohort: Age Effects and Cognitive Trajectories
- (2020) Stefanie Lerche et al. MOVEMENT DISORDERS
- Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson’s Disease Progression
- (2020) Brit Mollenhauer et al. MOVEMENT DISORDERS
- Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology
- (2019) Claire Bridel et al. JAMA Neurology
- Neurofilament Light Chain in Cerebrospinal Fluid and Blood as a Biomarker for Neurodegenerative Diseases: A Systematic Review and Meta-Analysis
- (2019) Shao-Yang Wang et al. JOURNAL OF ALZHEIMERS DISEASE
- Unlocking the mystery of biomarkers: A brief introduction, challenges and opportunities in Parkinson Disease
- (2018) Thomas F. Tropea et al. PARKINSONISM & RELATED DISORDERS
- Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa)
- (2018) Brit Mollenhauer et al. MOVEMENT DISORDERS
- Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease
- (2018) Yung-Shuan Lin et al. Scientific Reports
- Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders
- (2018) Bob Olsson et al. JAMA Neurology
- Blood-based NfL
- (2017) Oskar Hansson et al. NEUROLOGY
- CSF biomarkers associated with disease heterogeneity in early Parkinson’s disease: the Parkinson’s Progression Markers Initiative study
- (2016) Ju-Hee Kang et al. ACTA NEUROPATHOLOGICA
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- Longitudinal study of normal cognition in Parkinson disease
- (2015) Kara Pigott et al. NEUROLOGY
- CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival
- (2014) T. Skillback et al. NEUROLOGY
- A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank
- (2013) Jon B. Toledo et al. Alzheimers & Dementia
- Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases
- (2013) Johanna Gaiottino et al. PLoS One
- Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
- (2012) Irene Litvan et al. MOVEMENT DISORDERS
- The Clinically Important Difference on the Unified Parkinson's Disease Rating Scale
- (2010) Lisa M. Shulman et al. ARCHIVES OF NEUROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started